Clinical decision making in castration-resistant prostate cancer according to baseline prostate-specific antigen

Are we measuring disease burden or disease biology?

Benjamin A. Gartrell, Matthew D. Galsky

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)231-232
Number of pages2
JournalEuropean Urology
Volume67
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Castration-Resistant Prostatic Neoplasms
Phenylthiohydantoin
Kallikreins
Castration
Prostate-Specific Antigen
Antineoplastic Agents
Prostatic Neoplasms
Clinical Decision-Making

ASJC Scopus subject areas

  • Urology

Cite this

@article{d0e826a8d41a4066b07bed8adfae6bb2,
title = "Clinical decision making in castration-resistant prostate cancer according to baseline prostate-specific antigen: Are we measuring disease burden or disease biology?",
author = "Gartrell, {Benjamin A.} and Galsky, {Matthew D.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.eururo.2014.08.069",
language = "English (US)",
volume = "67",
pages = "231--232",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Clinical decision making in castration-resistant prostate cancer according to baseline prostate-specific antigen

T2 - Are we measuring disease burden or disease biology?

AU - Gartrell, Benjamin A.

AU - Galsky, Matthew D.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84920656318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920656318&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2014.08.069

DO - 10.1016/j.eururo.2014.08.069

M3 - Article

VL - 67

SP - 231

EP - 232

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 2

ER -